Show
Sort by
-
- Journal Article
- A1
- open access
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
-
- Journal Article
- A1
- open access
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
-
- Journal Article
- A1
- open access
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function
-
- Journal Article
- A1
- open access
Viral interference of hepatitis C and E virus replication in novel experimental co-infection systems
-
- Journal Article
- A1
- open access
Study of hepatitis E virus-4 infection in human liver-chimeric, immunodeficient, and immunocompetent mice
-
- Journal Article
- A1
- open access
A role for B cells to transmit hepatitis C virus infection
-
- Journal Article
- A1
- open access
Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections
-
- Journal Article
- A1
- open access
Inflammation alters the secretome and immunomodulatory properties of human skin-derived precursor cells
-
- Journal Article
- A1
- open access
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice
-
- Journal Article
- A1
- open access
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes
(2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(3). p.1678-1688 -
- Journal Article
- A1
- open access
Robust hepatitis E virus infection and transcriptional response in human hepatocytes
(2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(3). p.1731-1741 -
Hepatitis E virus prevalence in Flemish blood donors
-
- Journal Article
- A1
- open access
Hepatitis E virus (HEV) open reading frame 2 antigen kinetics in human-liver chimeric mice and its impact on HEV diagnosis
-
- Journal Article
- A1
- open access
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
-
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
-
A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
-
Characterization of a novel monoclonal antibody targeting epitope II within hepatitis C virus E2 envelope glycoprotein
-
Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
-
Successful engraftment of human hepatocytes in uPA-SCID and FRG® KO mice
(2017) Hepatocyte transplantation : methods and protocols. In Methods in Molecular Biology 1506. p.117-130 -
Effect of hepatitis E virus infection on the human hepatic innate immune response in human liver chimeric mice
-
Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma
-
- Conference Paper
- C3
- open access
Development and characterization of a human monoclonal antibody for prevention of HCV recurrence in liver transplant patients
-
- Conference Paper
- C3
- open access
Impact of HEV infection on the human hepatic innate immune response in human liver chimeric mice
-
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver
-
- Conference Paper
- C3
- open access
Effect of hepatitis E virus infection on the human hepatic innate immune response in human liver chimeric mice
-
Characterization of a novel human monoclonal antibody targeting the hepatitis C virus envelope protein
-
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge
-
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
-
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
-
- Conference Paper
- C3
- open access
Human liver chimeric mice as a novel model for the study of hepatitis E virus infections
-
A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver
-
A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver
-
- Conference Paper
- C3
- open access
Human liver chimeric mice as a novel model for the study of hepatitis E virus infections
-
A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver
-
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
-
Human liver chimeric mice as a novel model for the study of hepatitis E virus infections
-
Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model
-
- Conference Paper
- C3
- open access
Human liver chimeric mice as a novel model for the study of hepatitis E virus infections
-
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses
-
99mTc-mebrofenin disposition in chimeric mice with a humanized liver
-
Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice
-
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
-
Griffithsin has antiviral activity against hepatitis C virus
-
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus
-
Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice
-
The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection
-
Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients